吕万良团队研究了一种体外表达基因编辑蛋白的重组靶向性生物纳米粒用于表皮生长因子受体突变型肺癌治疗
北京大学药学院天然药物及仿生药物全国重点实验室
The research team of Prof. Wanliang Lu studied a recombinant targeted biological nanoparticle for in vitro expression of gene-editing proteins for epidermal growth factor receptor mutant lung cancer
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2026, (3): 327
-327
.
>
>